lidocaine has been researched along with EHS Tumor in 1 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Robins, HI | 1 |
| Dennis, WH | 1 |
| Slattery, JS | 1 |
| Lange, TA | 1 |
| Yatvin, MB | 1 |
1 other study available for lidocaine and EHS Tumor
| Article | Year |
|---|---|
Systemic lidocaine enhancement of hyperthermia-induced tumor regression in transplantable murine tumor models.
Topics: Animals; Female; Hot Temperature; Lidocaine; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbr | 1983 |